Clinical Trials
16
Active:1
Completed:6
Trial Phases
4 Phases
Phase 1:1
Phase 3:11
Phase 4:2
+1 more phases
Drug Approvals
8
PHILIPPINES:8
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Phase 3
11 (73.3%)Phase 4
2 (13.3%)Not Applicable
1 (6.7%)Phase 1
1 (6.7%)Recombinant Follicle-stimulating Hormone in Treatment for Infertility
Phase 3
Active, not recruiting
- Conditions
- Female Infertility
- Interventions
- Drug: Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 250
- Registration Number
- NCT05266924
- Locations
- 🇮🇳
Om Research Center Om Surgical Center and Maternity Home, Varanasi, Uttar Pradesh, India
Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer
Phase 3
Completed
- Conditions
- Advanced Prostate Adenocarcinoma
- Interventions
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 155
- Registration Number
- NCT04914195
- Locations
- 🇮🇳
Government Med ical College & Superspeciality Hospital Nagpur, Nagpur, Maharashtra, India
🇮🇳MV hospital and Research Center, Lucknow, Uttar Pradesh, India
Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
Phase 1
Terminated
- Conditions
- SARS-CoV-2 Infection
- Interventions
- Biological: Equine COVID-19 AntiserumDrug: Standard of care
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 7
- Registration Number
- NCT04834908
- Locations
- 🇮🇳
Jehangir Hospital, Pune, Maharashtra, India
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Phase 3
Completed
- Conditions
- Leishmaniasis, Visceral
- Interventions
- Drug: Amphotericin B Lipid emulsion
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2011-06-02
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 500
- Registration Number
- NCT00876824
News
No news found